Table 4.
Mean of FEV1%, FVC% and FEV1/FVC ratio according to quartiles of HOMA-IR.
| HOMA-IR | FEV1% predicted | FVC% predicted | FEV1/FVC ratio | |||
|---|---|---|---|---|---|---|
| No-asthma | Asthma | No-asthma | Asthma | No-asthma | Asthma | |
| Quartile 1 | 96.2 ± 0.5 | 88.1 ± 1.5 | 97.4 ± 0.5 | 93.9 ± 1.6 | 0.841 ± 0.003 | 0.803 ± 0.014 |
| Quartile 2 | 94.8 ± 0.6 | 90.6 ± 1.4 | 95.9 ± 0.6 | 94.8 ± 1.4 | 0.841 ± 0.003 | 0.814 ± 0.010 |
| Quartile 3 | 92.7 ± 0.6 | 91.4 ± 1.6 | 94.2 ± 0.5 | 93.8 ± 1.4 | 0.837 ± 0.003 | 0.828 ± 0.008 |
| Quartile 4 | 91.8 ± 0.6 | 88.9 ± 1.6 | 93.1 ± 0.5 | 92.3 ± 1.5 | 0.838 ± 0.003 | 0.820 ± 0.010 |
| P value | <0.0001 | 0.4004 | <0.0001 | 0.7446 | 0.7131 | 0.4019 |
| P value for interaction | 0.187 | 0.8567 | 0.35 | |||
HOMA-IR, homeostasis model of assessment of insulin resistance; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.